Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer
出版年份 2020 全文链接
标题
Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer
作者
关键词
Lesions, Prostate cancer, Metastasis, Computed axial tomography, Lymph nodes, Positron emission tomography, Magnetic resonance imaging, Cancer detection and diagnosis
出版物
PLoS One
Volume 15, Issue 10, Pages e0239414
出版商
Public Library of Science (PLoS)
发表日期
2020-10-07
DOI
10.1371/journal.pone.0239414
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?
- (2020) Peter Donato et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
- (2019) Jeremie Calais et al. LANCET ONCOLOGY
- Prostate-Specific Membrane Antigen Ligand Positron-Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer
- (2019) Wolfgang P Fendler et al. CLINICAL CANCER RESEARCH
- PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA–targeted PET Imaging Studies
- (2018) Steven P. Rowe et al. EUROPEAN UROLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making
- (2017) B. Grubmüller et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
- (2017) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
- (2017) Philip Cornford et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
- (2017) Matthias Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Prostate Cancer
- (2017) James Mohler et al. Journal of the National Comprehensive Cancer Network
- 68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
- (2016) Pim J. van Leeuwen et al. BJU INTERNATIONAL
- Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
- (2016) Sander Greenland et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- An improved synthesis of the radiolabeled prostate-specific membrane antigen inhibitor, [18F]DCFPyL
- (2016) Hayden T. Ravert et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges
- (2016) S P Rowe et al. PROSTATE CANCER AND PROSTATIC DISEASES
- 68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
- (2016) Isabel Rauscher et al. CANCER IMAGING
- Automated synthesis of [18F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models
- (2016) Vincent Bouvet et al. EJNMMI Research
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
- (2015) J. J. Morigi et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
- (2015) Markus Dietlein et al. MOLECULAR IMAGING AND BIOLOGY
- The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
- (2014) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Repeatability of Metabolically Active Tumor Volume Measurements with FDG PET/CT in Advanced Gastrointestinal Malignancies: A Multicenter Study
- (2014) Virginie Frings et al. RADIOLOGY
- Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
- (2013) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography
- (2012) Alejandro Sanchez-Crespo APPLIED RADIATION AND ISOTOPES
- 2-(3- -Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
- (2011) Y. Chen et al. CLINICAL CANCER RESEARCH
- Lymphatic Metastases from Pelvic Tumors: Anatomic Classification, Characterization, and Staging
- (2009) Colm J. McMahon et al. RADIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search